Tracking CF Lung Disease Through the Early Years: Utility of the LCI

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

September 1, 2021

Conditions
Observational
Interventions
OTHER

This is an observational study, no intervention used.

No intervention is being used in this study.

Trial Locations (1)

M5G1X8

Hospital for Sick Children, Toronto

All Listed Sponsors
lead

Felix Ratjen

OTHER

NCT03138772 - Tracking CF Lung Disease Through the Early Years: Utility of the LCI | Biotech Hunter | Biotech Hunter